Xywav (calcium, magnesium, potassium, and sodium oxybates) is a brand-name oral solution prescribed for idiopathic hypersomnia (IH) in adults. This article covers topics such as side effects , Consider XYWAV treatment for your patients; use the IH patient identification form to determine if XYWAV is right for your patient. See full Prescribing Information & BOXED Warning about serious side effects, CNS depression, and misuse and abuse., Xywav is the first medication approved to treat idiopathic hypersomnia (IH). Find out how Xywav works and more here., The effectiveness of Xywav was evaluated in a double-blind placebo-controlled randomized-withdrawal study in 154 adult patients (ages 19 to 75 years) with IH., There's another way to manage IH: XYWAV, the first and only FDA-approved treatment for adults with IH. Unlike stimulants and wake-promoting agents that are taken during the day, XYWAV is taken at night to help treat multiple symptoms of Idiopathic Hypersomnia, such as excessive daytime sleepiness, sleep inertia (severe grogginess or confusion , The DUET trial is a Phase 4, prospective, single-arm, open-label study to assess the effect of Xywav treatment on EDS, polysomnography parameters, and functional outcomes in adults with narcolepsy or IH..